Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FRESENIUS KABI USA

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 36
  • 0 comments

FDA approve BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 36
  • 0 comments

FDA approve BUPIVACAINE HYDROCHLORIDE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 35
  • 0 comments

FDA approve BUPIVACAINE HYDROCHLORIDE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Nov. 18, 2022, 12:40 UTC
  • 38
  • 0 comments

FDA approve BUPIVACAINE HYDROCHLORIDE

Comment Full text

VALEANT PHARMS INTL

  • FDA Approval
  • Nov. 17, 2022, 12:39 UTC
  • 30
  • 0 comments

FDA approve MESALAMINE

Comment Full text

TAKEDA PHARMS USA

  • FDA Approval
  • Nov. 17, 2022, 12:39 UTC
  • 26
  • 0 comments

FDA approve MESALAMINE

Comment Full text

APIL

  • FDA Approval
  • Nov. 17, 2022, 12:39 UTC
  • 36
  • 0 comments

FDA approve MESALAMINE

Comment Full text

ALLERGAN

  • FDA Approval
  • Nov. 17, 2022, 12:39 UTC
  • 30
  • 0 comments

FDA approve MESALAMINE

Comment Full text

VALEANT PHARMS INTL

  • FDA Approval
  • Nov. 17, 2022, 12:39 UTC
  • 34
  • 0 comments

FDA approve BALSALAZIDE DISODIUM

Comment Full text

APIL

  • FDA Approval
  • Nov. 17, 2022, 12:39 UTC
  • 29
  • 0 comments

FDA approve MESALAMINE

Comment Full text
  • Previous
  • 938
  • 939
  • 940
  • 941
  • 942
  • Next

Search

News categories

  • Technical Exchange News(12316)
  • Event(6229)
  • SEC News(268260)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(156256)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin